ENTITY
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
PulseAugur coverage of Regeneron Pharmaceuticals — every cluster mentioning Regeneron Pharmaceuticals across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
FDA approves first gene therapy for genetic deafness
The FDA has approved the first gene therapy designed to treat deafness caused by a specific genetic mutation. This groundbreaking treatment targets the OTOF gene, which is crucial for transmitting sound signals from the…
-
Trump secures final drug price deal with Regeneron
President Trump announced a drug pricing agreement with Regeneron, finalizing a series of deals with 17 manufacturers pressured to adopt his "most favored nation" policy. These agreements aim to lower prices for certain…